SUNSHINE GUOJIAN PHARMACEUTICAL(SHANGHAI)CO,.LTDSUNSHINE GUOJIAN PHARMACEUTICAL(SHANGHAI)CO,.LTDSUNSHINE GUOJIAN PHARMACEUTICAL(SHANGHAI)CO,.LTD

SUNSHINE GUOJIAN PHARMACEUTICAL(SHANGHAI)CO,.LTD

No trades
See on Supercharts

688336 fundamentals

SUNSHINE GUOJIAN PHARMACEUTICAL(SHANGHAI)CO,.LTD revenue breakdown overview

SUNSHINE GUOJIAN PHARMACEUTICAL(SHANGHAI)CO,.LTD revenue for the last year amounted to 1.01 B CNY, the most of which — 1.01 B CNY — came from its highest performing source at the moment, Antibody Drugs, the year earlier bringing 825.49 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SUNSHINE GUOJIAN PHARMACEUTICAL(SHANGHAI)CO,.LTD 1.01 B CNY, and the year before that — 794.89 M CNY.

By source
By country